Insilico Medicine was valued at about $895 million after raising $95 million last July from the likes of leading Chinese healthcare-focused firm Qiming Venture Partners and billionaire Eduardo Saverin’s B Capital, among others.
Category: Markets
Shares Of Weight Watchers Parent Surge 60% After Pivot To Ozempic
WW International’s newly acquired telehealth unit—which specializes in helping patients get prescription weight management drugs like Ozempic—could serve as an “on-ramp” to the company’s traditional weight loss programs, Goldman Sachs says.
Amazon Completes $3.9bn One Medical Acquisition After FTC’s Antitrust Challenge Times Out
Stock prices for Amazon and One Medical jumped despite the FTC’s warning
Synchron: Brain Hacking With A Purpose
Exciting startup Synchron offers a revolutionary brain-computer interface solution for people with paralysis and other conditions
Pfizer Expects Covid Vaccine And Pill Revenues Will Fall 60% In 2023
Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer’s core products combatting Covid-19.
Italy Orders Covid Tests For China Arrivals, U.S. Weighs Rules
Italy was hit hard as Covid spread from China in the early phase of the pandemic in 2020
‘Pharma Bro’ Shkreli Plots Post-Jail NYC Return—Seeks Home In ‘Dope Building With Sick Views’
The notorious investor is reemerging from his prison sentence and back on social media.
Signify Health Stock Surges As Amazon Reportedly Joins Potential Bidding War With CVS, UnitedHealth
Share of Signify jumped 40% on reports that a bidding war could value the firm at more than $8 billion.
Cathie Wood’s Ark Invest Buys Moderna Stock After $100 Billion Crash—And Sells Rival Vaccine Maker Pfizer
Shares of Moderna have tumbled 40% this year, Ark’s Genomic Revolution ETF nearly 50%.
China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers
Purchase to help expansion in Southeast Asia
